KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Accumulated Expenses (2017 - 2025)

Guardant Health's Accumulated Expenses history spans 9 years, with the latest figure at $71.7 million for Q3 2025.

  • For Q3 2025, Accumulated Expenses changed N/A year-over-year to $71.7 million; the TTM value through Sep 2025 reached $71.7 million, changed N/A, while the annual FY2024 figure was $68.3 million, 6.04% down from the prior year.
  • Accumulated Expenses for Q3 2025 was $71.7 million at Guardant Health, up from $63.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $190.5 million in Q1 2023 and bottomed at $34.7 million in Q2 2021.
  • The 5-year median for Accumulated Expenses is $68.3 million (2024), against an average of $84.6 million.
  • The largest annual shift saw Accumulated Expenses soared 288.25% in 2022 before it plummeted 58.63% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $45.3 million in 2021, then skyrocketed by 288.25% to $175.8 million in 2022, then tumbled by 58.63% to $72.7 million in 2023, then dropped by 6.04% to $68.3 million in 2024, then increased by 4.92% to $71.7 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Accumulated Expenses are $71.7 million (Q3 2025), $63.7 million (Q1 2025), and $68.3 million (Q4 2024).